214 related articles for article (PubMed ID: 22033347)
1. Prognostic value of change in red cell distribution width 1 month after discharge in acute decompensated heart failure patients.
Oh J; Kang SM; Won H; Hong N; Kim SY; Park S; Lee SH; Jang Y; Chung N
Circ J; 2012; 76(1):109-16. PubMed ID: 22033347
[TBL] [Abstract][Full Text] [Related]
2. Elevation of red blood cell distribution width during hospitalization predicts mortality in patients with acute decompensated heart failure.
Uemura Y; Shibata R; Takemoto K; Uchikawa T; Koyasu M; Watanabe H; Mitsuda T; Miura A; Imai R; Watarai M; Murohara T
J Cardiol; 2016 Mar; 67(3):268-73. PubMed ID: 26140955
[TBL] [Abstract][Full Text] [Related]
3. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
Ueda T; Kawakami R; Sugawara Y; Okada S; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
J Am Heart Assoc; 2014 Nov; 3(6):e001174. PubMed ID: 25370599
[TBL] [Abstract][Full Text] [Related]
4. Comparison of prognostic value of red cell distribution width and NT-proBNP for short-term clinical outcomes in acute heart failure patients.
He W; Jia J; Chen J; Qin S; Tao H; Kong Q; Xue Q; Zhang D
Int Heart J; 2014; 55(1):58-64. PubMed ID: 24463920
[TBL] [Abstract][Full Text] [Related]
5. Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure.
Makhoul BF; Khourieh A; Kaplan M; Bahouth F; Aronson D; Azzam ZS
Int J Cardiol; 2013 Aug; 167(4):1412-6. PubMed ID: 22560496
[TBL] [Abstract][Full Text] [Related]
6. Combined Assessment of the Red Cell Distribution Width and B-type Natriuretic Peptide: A More Useful Prognostic Marker of Cardiovascular Mortality in Heart Failure Patients.
Kawasoe S; Kubozono T; Ojima S; Miyata M; Ohishi M
Intern Med; 2018 Jun; 57(12):1681-1688. PubMed ID: 29434163
[TBL] [Abstract][Full Text] [Related]
7. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
[TBL] [Abstract][Full Text] [Related]
8. Bio-width index: a novel biomarker for prognostication of long term outcomes in patients with anaemia and heart failure.
Subramanian M; Prabhu MA; Saravanan S; Thachathodiyl R
Acta Cardiol; 2018 Aug; 73(4):403-409. PubMed ID: 29214898
[TBL] [Abstract][Full Text] [Related]
9. Impact of red blood cell distribution width on non-cardiac mortality in patients with acute decompensated heart failure with preserved ejection fraction.
Imai R; Uemura Y; Okumura T; Takemoto K; Uchikawa T; Koyasu M; Ishikawa S; Iwamiya S; Ozaki Y; Shibata R; Watarai M; Murohara T
J Cardiol; 2017 Dec; 70(6):591-597. PubMed ID: 28522136
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
[TBL] [Abstract][Full Text] [Related]
11. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE
Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037
[TBL] [Abstract][Full Text] [Related]
12. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
[TBL] [Abstract][Full Text] [Related]
13. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F
J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712
[TBL] [Abstract][Full Text] [Related]
14. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
Eur J Heart Fail; 2015 Sep; 17(9):936-44. PubMed ID: 26222618
[TBL] [Abstract][Full Text] [Related]
15. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Grodin JL; Perez AL; Wu Y; Hernandez AF; Butler J; Metra M; Felker GM; Voors AA; McMurray JJ; Armstrong PW; Califf RM; Starling RC; O'Connor CM; Tang WH
JACC Heart Fail; 2015 Oct; 3(10):777-85. PubMed ID: 26449997
[TBL] [Abstract][Full Text] [Related]
16. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
[TBL] [Abstract][Full Text] [Related]
17. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients.
Berezin AE; Kremzer AA; Samura TA; Martovitskaya YV; Malinovskiy YV; Oleshko SV; Berezina TA
J Cardiol; 2015 May; 65(5):403-11. PubMed ID: 25123603
[TBL] [Abstract][Full Text] [Related]
19. Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.
Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
JACC Heart Fail; 2016 Sep; 4(9):736-45. PubMed ID: 27395353
[TBL] [Abstract][Full Text] [Related]
20. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE
J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
